Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C)

INTRODUCTION: National Comprehensive Cancer Network HCC guidelines recommend Y90 to treat BCLC-C patients only in select cases given the development of systemic regimens. We sought to identify ideal candidates for Y90 by assessing survival and toxicities in this patient group. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Goswami, Pulak, Adeniran, Oladapo R., K. Frantz, Shelby, Matsuoka, Lea, Du, Liping, Gandhi, Ripal T., Collins, Zachary S., Matrana, Marc R., Petroziello, Michael, Brower, Jayson S., Sze, Daniel Y., Kennedy, Andrew S., Golzarian, Jafar, Wang, Eric A., Brown, Daniel B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670475/
https://www.ncbi.nlm.nih.gov/pubmed/36396989
http://dx.doi.org/10.1186/s12876-022-02528-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670475/
https://www.ncbi.nlm.nih.gov/pubmed/36396989
http://dx.doi.org/10.1186/s12876-022-02528-y

Ejemplares similares